Skip to main content
Healthcare

STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

STAT+: FDA offers new details on quicker approval pathway for personalized gene therapies

Feed excerpt — reported by STAT News

FDA draft rules would create Individualized Feature Space framework to update personalized gene editing therapies without a new Biologics License Application.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.